TytoCare
- Industry
- Health Care
- Founded Year
- 2011
- Headquarters
- New York, NY, USA
- Employee Count
- 267
Key People
- Dedi Gilad - CEO & Co-Founder
- Ofer Tzadik - COO & Co-Founder
- Elad Lachmanovich - VP of Research and Development
- David Israel - VP of Strategy and Operations
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a strong background in MedTech.
The leadership team, including CEO Dedi Gilad and COO Ofer Tzadik, brings significant experience in the MedTech industry, enhancing the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: TytoCare addresses a critical need for remote medical examinations, especially in underserved areas.
TytoCare's platform enables comprehensive remote medical examinations, filling a significant gap in telehealth by allowing physical exams to be conducted remotely, which is crucial for patient care continuity.
- Competition
-
Aspect: Somewhat crowded
Summary: The telehealth market is competitive, with several established players.
While TytoCare offers unique features, it operates in a market with significant competition from other telehealth providers, which may impact market share and growth potential.
- Technical Challenge
-
Aspect: Predictable
Summary: The technology is well-developed and has been successfully implemented.
TytoCare's platform has been effectively deployed across various health systems, demonstrating its technical reliability and scalability in real-world settings.
- Patent
-
Aspect: Strong
Summary: TytoCare holds patents that protect its innovative telehealth solutions.
Holding strong patents allows TytoCare to safeguard its unique technologies, reducing the risk of imitation and enhancing its market position.
- Financing
-
Aspect: Well-funded
Summary: TytoCare has secured substantial funding from reputable investors.
With significant investments from firms like Insight Partners and OrbiMed, TytoCare is well-positioned to expand its operations and enhance its product offerings.
- Regulatory
-
Aspect: 510k/PMA
Summary: TytoCare's products have received necessary regulatory approvals.
Achieving 510(k) clearance indicates that TytoCare's devices are safe and effective, facilitating their adoption in clinical settings.
Opportunity Rollup
- Odds of Success
- 3.7
- Peak Market Share
- 4.7
- Segment CAGR
- 10.7%
- Market Segment
- Telehealth
- Market Sub Segment
- Remote Patient Monitoring
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.70 |
| 3 | 1.64 |
| 4 | 3.29 |
| 5 | 4.70 |
Key Takeaway
TytoCare is well-positioned in the growing telehealth market, offering innovative remote examination solutions backed by strong leadership and substantial funding.